CompaniesAlzinova
Alzinova logo

Alzinova

active
Mölndal, Sweden
Founded 2011
Website
About

Alzheimer's Vaccine, Monoclonal Antibody Technology

Areas of Focus

Categories

Biologics & BiopharmaceuticalVaccineAntibody
Clinical Trials (1)
View all

Total Trials

1

As Lead Sponsor

1

As Collaborator

0

Total Enrollment

33

By Phase

PHASE1: 1

By Status

COMPLETED: 1
Clinical Trials Pipeline1 trial
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2020
2021
2022
2023
2024
2025
2026
Today
NCT05328115
Hover over trial bars to see details

Recent Trials

NCT05328115Lead Sponsor
A Study on the Safety, Tolerability and Immunogenicity of ALZ-101 in Participants With Early Alzheimer's Disease
PHASE1Completed
33 participants
Started: Sep 30, 2021 · Completed: Jan 27, 2025
Locations (1)
Headquarters
Mölndal, Sweden
Map

Loading map...